Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Craig Johnson


  • Director at La Jolla Pharmaceutical Co (LJPC), 2020-01-13
  • at Mirati Therapeutics Inc. (MRTX), 2020-01-08
  • Director at Heron Therapeutics Inc. (HRTX), 2019-12-23
  • Director at Odonate Therapeutics Inc. (ODT), 2019-12-12
  • Director at Adamis Pharmaceuticals Corp (ADMP), 2013-10-17
  • Director at Ardea Biosciences Inc. (RDEA), 2012-06-20
  • Chief Financial Officer at Pure Bioscience Inc. (PURE), 2011-08-02
  • Sr. Vp, Cfo And Secretary at Novadel Pharma Inc (NVDL.OB), 2010-06-17
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRTX $61.80 8,525 0 2019-01-29 Filing
MRTX $61.11 8,475 8,525 2019-01-29 Filing
RDEA $23.16 1,000 Director 0 2011-08-01 Filing
RDEA $26.60 477 Director 0 2011-07-01 Filing
RDEA $26.13 1,523 Director 477 2011-07-01 Filing